Research ArticleCancer
Eradication of spontaneous malignancy by local immunotherapy
- Idit Sagiv-Barfi1,
- Debra K. Czerwinski1,
- Shoshana Levy1,
- Israt S. Alam2,
- Aaron T. Mayer2,
- Sanjiv S. Gambhir2 and
- Ronald Levy1,*
- 1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
- 2Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
- ↵*Corresponding author. Email: levy{at}stanford.edu
See allHide authors and affiliations
Science Translational Medicine 31 Jan 2018:
Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488
Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488
Idit Sagiv-Barfi
Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Debra K. Czerwinski
Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Shoshana Levy
Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Israt S. Alam
Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Aaron T. Mayer
Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Sanjiv S. Gambhir
Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Ronald Levy
Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
